Hims & Hers Health, Inc. Share Price

Equities

HIMS

US4330001060

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 12:42:19 18/07/2024 am IST 5-day change 1st Jan Change
22.18 USD -4.05% Intraday chart for Hims & Hers Health, Inc. +9.45% +148.54%
Sales 2024 * 124.92Cr 10TCr Sales 2025 * 160.63Cr 13TCr Capitalization 496.37Cr 41TCr
Net income 2024 * 4.2Cr 350.82Cr Net income 2025 * 7.4Cr 618.11Cr EV / Sales 2024 * 3.8 x
Net cash position 2024 * 22Cr 1.81TCr Net cash position 2025 * 42Cr 3.49TCr EV / Sales 2025 * 2.83 x
P/E ratio 2024 *
131 x
P/E ratio 2025 *
69 x
Employees 1,046
Yield 2024 *
-
Yield 2025 *
-
Free-Float 83.05%
More Fundamentals * Assessed data
Dynamic Chart
TD Cowen Adjusts Price Target on Hims & Hers Health to $25 From $15, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $18 From $16, Maintains Neutral Rating MT
Hims & Hers Health Insider Sold Shares Worth $1,089,828, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $6,907,500, According to a Recent SEC Filing MT
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Friday; Trump Media & Technology Group to Advance, Nike to Decline MT
Jefferies Adjusts Price Target on Hims & Hers Health to $23 From $14, Maintains Hold Rating MT
Hims & Hers Health Insider Sold Shares Worth $1,051,087, According to a Recent SEC Filing MT
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Thursday; Broadcom, Tesla to Advance MT
Hims & Hers Health Insider Sold Shares Worth $8,649,194, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $2,113,225, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $6,626,198, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $2,171,787, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $10,319,439, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $2,665,244, According to a Recent SEC Filing MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Pre-Bell Wednesday; CAVA Group, Hims & Hers Health to Decline MT
More news

Latest transcript on Hims & Hers Health, Inc.

1 day-4.05%
1 week+9.45%
Current month+9.56%
1 month-8.41%
3 months+78.24%
6 months+163.02%
Current year+148.54%
More quotes
1 week
20.62
Extreme 20.62
23.96
1 month
18.80
Extreme 18.8
25.74
Current year
8.09
Extreme 8.09
25.74
1 year
5.65
Extreme 5.65
25.74
3 years
2.72
Extreme 2.72
25.74
5 years
2.72
Extreme 2.72
25.74
10 years
2.72
Extreme 2.72
25.74
More quotes
Managers TitleAgeSince
Chief Executive Officer 35 20/21/20
Director of Finance/CFO 38 24/22/24
Chief Tech/Sci/R&D Officer 66 01/19/01
Members of the board TitleAgeSince
Director/Board Member 83 20/21/20
Director/Board Member 41 01/17/01
Director/Board Member 49 20/21/20
More insiders
Date Price Change Volume
18/24/18 22.11 -4.33% 4 213 159
16/24/16 23.11 +1.18% 7,128,769
15/24/15 22.84 +5.16% 8,121,921
12/24/12 21.72 +3.18% 8,662,246
11/24/11 21.05 +4.16% 6,380,325

Delayed Quote Nyse, July 18, 2024 at 12:27 am IST

More quotes
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. The Company’s digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The Company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
23.11 USD
Average target price
20.38 USD
Spread / Average Target
-11.79%
Consensus